Bristol Myers Squibb (BMY)

EBITDA Margin

39.21%

Quarterly · Period ending:

BMY logo

BMY EBITDA Margin

Latest reported39.21%
BMY Quarterly EBITDA Margin (100.00% → 39.21%)
High-resolution chart · PNG

BMY ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb EBITDA Margin — Quarterly
Period endingEBITDA Margin
39.2122%
36.9484%
23.0265%
37.678%
26.6444%
39.9696%
20.6693%
40.1362%
36.0872%
-72.1365%
38.8081%
44.2459%
40.7358%
48.399%
40.9784%
45.427%
40.8345%
39.466%
39.7163%
44.8383%
39.2634%
50.1309%
-66.9136%
49.8861%
44.8415%
23.5136%
17.4449%
28.7831%
32.9667%
37.0608%
28.88%
41.7501%
12.6052%
37.8972%
17.361%
27.008%
30.2877%
44.4918%
23.8032%
34.6607%
35.8653%
40.1503%
-6.788%
27.8447%
4.6121%
39.6684%
2.2546%
29.8393%
15.6596%
30.858%
24.8367%
25.6827%
18.997%
24.4584%
18.2057%
-27.1949%
28.0891%
42.0491%
33.7917%
36.5949%
37.3206%
39.6727%
32.342%
37.9325%
38.0663%
34.7826%
35.4209%
32.6772%
32.3366%
28.1954%
42.4271%
26.6083%
28.5989%
29.5503%
17.8177%
21.604%
21.5097%
22.3637%
10.6812%
16.5623%
26.0111%
24.444%
21.4186%
25.1101%
27.6948%
27.6699%
37.1035%
25.9812%
25.0276%
26.0181%
24.2837%
29.7171%
28.4442%
27.7436%
22.2778%
27.8378%
25.512%
40.7888%
32.4688%
34.767%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.